We are live on ! Find out more
PIA

Piedmont Investment Advisors Portfolio holdings

AUM $2.53B
1-Year Est. Return 0.83%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+0.83%
3 Year Est. Return
+35.37%
5 Year Est. Return
+69.82%
10 Year Est. Return
AUM
$2.89B
AUM Growth
+$305M
Cap. Flow
+$65.4M
Cap. Flow %
2.26%
Top 10 Hldgs %
26.78%
Holding
942
New
45
Increased
483
Reduced
384
Closed
30

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$17M
2
PFE icon
Pfizer
PFE
+$11.6M
3
LIN icon
Linde
LIN
+$9.28M
4
NKE icon
Nike
NKE
+$8.56M
5
PRU icon
Prudential Financial
PRU
+$7.44M

Sector Composition

Rank Sector Weight
1 Technology 25.58%
2 Healthcare 14.02%
3 Financials 13.08%
4 Communication Services 10.42%
5 Consumer Discretionary 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAP icon
776
Molson Coors Class B
TAP
$7.93B
$283K 0.01%
5,251
+599
+13% +$32.2K
WRI
777
DELISTED
Weingarten Realty Investors
WRI
$283K 0.01%
9,063
-1,752
-16% -$53.6K
CADE
778
DELISTED
Cadence Bank
CADE
$282K 0.01%
8,973
-1,051
-10% -$32.5K
CE icon
779
Celanese
CE
$4.88B
$282K 0.01%
2,292
+365
+19% +$44.9K
MAA icon
780
Mid-America Apartment Communities
MAA
$15.4B
$282K 0.01%
2,136
+361
+20% +$48.3K
HOMB icon
781
Home BancShares
HOMB
$6.17B
$281K 0.01%
14,304
-2,154
-13% -$40.6K
KMT icon
782
Kennametal
KMT
$2.41B
$280K 0.01%
7,593
-1,098
-13% -$36.8K
CPRI icon
783
Capri Holdings
CPRI
$1.75B
$279K 0.01%
7,311
+410
+6% +$14.2K
EVRG icon
784
Evergy
EVRG
$18.9B
$278K 0.01%
4,278
+600
+16% +$38.3K
GEN icon
785
Gen Digital
GEN
$17.5B
$278K 0.01%
10,894
+2,108
+24% +$51.5K
SAGE
786
DELISTED
Sage Therapeutics
SAGE
$278K 0.01%
3,854
+131
+4% +$16.1K
OZK icon
787
Bank OZK
OZK
$5.63B
$277K 0.01%
9,088
-1,716
-16% -$50.3K
HSIC icon
788
Henry Schein
HSIC
$9.82B
$276K 0.01%
4,143
+521
+14% +$34.5K
GT icon
789
Goodyear
GT
$1.74B
$275K 0.01%
17,682
-3,076
-15% -$48.1K
MRNA icon
790
Moderna
MRNA
$23.9B
$275K 0.01%
14,066
+567
+4% +$10.1K
UMBF icon
791
UMB Financial
UMBF
$11.1B
$274K 0.01%
3,997
-599
-13% -$39.7K
TIF
792
DELISTED
Tiffany & Co.
TIF
$274K 0.01%
+2,050
New +$242K
CF icon
793
CF Industries
CF
$18.4B
$273K 0.01%
5,726
+643
+13% +$30.1K
COHR icon
794
Coherent
COHR
$63.6B
$273K 0.01%
8,101
-1,308
-14% -$41.7K
CLGX
795
DELISTED
Corelogic, Inc.
CLGX
$273K 0.01%
6,240
-1,162
-16% -$49.4K
CNK icon
796
Cinemark Holdings
CNK
$4.38B
$271K 0.01%
8,020
-1,536
-16% -$54.3K
UAA icon
797
Under Armour
UAA
$2.52B
$271K 0.01%
12,565
+737
+6% +$14.3K
DGX icon
798
Quest Diagnostics
DGX
$26.2B
$270K 0.01%
2,528
+423
+20% +$44.1K
KBH icon
799
KB Home
KBH
$3.47B
$268K 0.01%
7,825
-1,265
-14% -$43.7K
CATY icon
800
Cathay General Bancorp
CATY
$4.23B
$267K 0.01%
7,004
-1,015
-13% -$37.1K

Similar funds

Piedmont Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Piedmont Investment Advisors held 942 positions worth $2.89B, up 12% from $2.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Piedmont Investment Advisors's Q4 2019 filing shows 45 new, 483 increased, 384 reduced and 30 closed positions. Its largest new stake was Hormel Foods: 137,108 shares worth $6.18M. The largest sale was Accenture, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Piedmont Investment Advisors's largest Q4 2019 buy was Hormel Foods: 137,108 shares worth $6.18M.
  • Piedmont Investment Advisors added most to PepsiCo in Q4 2019, an estimated $17M increase.
  • Piedmont Investment Advisors's biggest Q4 2019 reduction was Accenture, cutting an estimated $14.1M.
  • Piedmont Investment Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $12M.
  • Piedmont Investment Advisors's ten largest holdings make up 27% of its $2.89B portfolio in Q4 2019.
  • Piedmont Investment Advisors opened 45 new positions and closed 30 in Q4 2019.
  • Piedmont Investment Advisors's portfolio value rose 12% quarter-over-quarter to $2.89B.

Based on Piedmont Investment Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.